Altogether, these results strongly suggest that CSF-1R is able to play an active role during prostate cancer development, which is in accordance with the previous studies demonstrating that CSF-1R expression is correlated with poor prognosis of prostate cancer [23,58]. Here, CSF1R is linked to prostate carcinoma.